Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

67 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
IL2 Inducible T-cell Kinase, a Novel Therapeutic Target in Melanoma.
Carson CC, Moschos SJ, Edmiston SN, Darr DB, Nikolaishvili-Feinberg N, Groben PA, Zhou X, Kuan PF, Pandey S, Chan KT, Jordan JL, Hao H, Frank JS, Hopkinson DA, Gibbs DC, Alldredge VD, Parrish E, Hanna SC, Berkowitz P, Rubenstein DS, Miller CR, Bear JE, Ollila DW, Sharpless NE, Conway K, Thomas NE. Carson CC, et al. Among authors: groben pa. Clin Cancer Res. 2015 May 1;21(9):2167-76. doi: 10.1158/1078-0432.CCR-14-1826. Clin Cancer Res. 2015. PMID: 25934889 Free PMC article.
DNA-methylation profiling distinguishes malignant melanomas from benign nevi.
Conway K, Edmiston SN, Khondker ZS, Groben PA, Zhou X, Chu H, Kuan PF, Hao H, Carson C, Berwick M, Olilla DW, Thomas NE. Conway K, et al. Among authors: groben pa. Pigment Cell Melanoma Res. 2011 Apr;24(2):352-60. doi: 10.1111/j.1755-148X.2011.00828.x. Epub 2011 Feb 18. Pigment Cell Melanoma Res. 2011. PMID: 21375697 Free PMC article.
Number of nevi and early-life ambient UV exposure are associated with BRAF-mutant melanoma.
Thomas NE, Edmiston SN, Alexander A, Millikan RC, Groben PA, Hao H, Tolbert D, Berwick M, Busam K, Begg CB, Mattingly D, Ollila DW, Tse CK, Hummer A, Lee-Taylor J, Conway K. Thomas NE, et al. Among authors: groben pa. Cancer Epidemiol Biomarkers Prev. 2007 May;16(5):991-7. doi: 10.1158/1055-9965.EPI-06-1038. Cancer Epidemiol Biomarkers Prev. 2007. PMID: 17507627
Validation of the VE1 immunostain for the BRAF V600E mutation in melanoma.
Pearlstein MV, Zedek DC, Ollila DW, Treece A, Gulley ML, Groben PA, Thomas NE. Pearlstein MV, et al. Among authors: groben pa. J Cutan Pathol. 2014 Sep;41(9):724-32. doi: 10.1111/cup.12364. Epub 2014 Jul 4. J Cutan Pathol. 2014. PMID: 24917033 Free PMC article.
DNA methylation profiles in primary cutaneous melanomas are associated with clinically significant pathologic features.
Thomas NE, Slater NA, Edmiston SN, Zhou X, Kuan PF, Groben PA, Carson CC, Hao H, Parrish E, Moschos SJ, Berwick M, Ollila DW, Conway K. Thomas NE, et al. Among authors: groben pa. Pigment Cell Melanoma Res. 2014 Nov;27(6):1097-105. doi: 10.1111/pcmr.12289. Epub 2014 Jul 14. Pigment Cell Melanoma Res. 2014. PMID: 24986547 Free PMC article.
Identification of a Robust Methylation Classifier for Cutaneous Melanoma Diagnosis.
Conway K, Edmiston SN, Parker JS, Kuan PF, Tsai YH, Groben PA, Zedek DC, Scott GA, Parrish EA, Hao H, Pearlstein MV, Frank JS, Carson CC, Wilkerson MD, Zhao X, Slater NA, Moschos SJ, Ollila DW, Thomas NE. Conway K, et al. Among authors: groben pa. J Invest Dermatol. 2019 Jun;139(6):1349-1361. doi: 10.1016/j.jid.2018.11.024. Epub 2018 Dec 6. J Invest Dermatol. 2019. PMID: 30529013 Free PMC article.
Tandem BRAF mutations in primary invasive melanomas.
Thomas NE, Alexander A, Edmiston SN, Parrish E, Millikan RC, Berwick M, Groben P, Ollila DW, Mattingly D, Conway K. Thomas NE, et al. J Invest Dermatol. 2004 May;122(5):1245-50. doi: 10.1111/j.0022-202X.2004.22523.x. J Invest Dermatol. 2004. PMID: 15140228 Free article.
Muir-Torre syndrome.
Lachiewicz AM, Wilkinson TM, Groben P, Ollila DW, Thomas NE. Lachiewicz AM, et al. Am J Clin Dermatol. 2007;8(5):315-9. doi: 10.2165/00128071-200708050-00008. Am J Clin Dermatol. 2007. PMID: 17902735
CD200 is induced by ERK and is a potential therapeutic target in melanoma.
Petermann KB, Rozenberg GI, Zedek D, Groben P, McKinnon K, Buehler C, Kim WY, Shields JM, Penland S, Bear JE, Thomas NE, Serody JS, Sharpless NE. Petermann KB, et al. J Clin Invest. 2007 Dec;117(12):3922-9. doi: 10.1172/JCI32163. J Clin Invest. 2007. PMID: 18008004 Free PMC article.
67 results